CompletedPhase 3ACTRN12608000235303
Topical capsaicin in burning mouth syndrome
The efficacy of topical capsaicin in reducing symptoms in patients with burning mouth syndrome
Sponsor
Sao Paulo University
Enrollment
20 participants
Start Date
Dec 10, 2007
Study Type
Interventional
Conditions
Eligibility
Sex: Both males and females
Inclusion Criteria1
- burning mouth syndrome, no recent use of other drugs
Exclusion Criteria1
- diabetic patients, anemia, candida infection
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Patients will be instructed to apply topical capsaicin 0.075%, twice a day (middle morning and middle afternoon) for 8 weeks with a one-week interval - the fourth.
Patients will be instructed to apply topical capsaicin 0.075%, twice a day (middle morning and middle afternoon) for 8 weeks with a one-week interval - the fourth.
Locations(1)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12608000235303
Related Trials
MucoLock™ for Treatment of Stomatitis
NCT075060181 location
Reducing Patient Memory Recall in the Burning Mouth Patient Population
NCT058196971 location
Effect of Treatments on Pain and Quality of Life in Individual With Burning Mouth Syndrome
NCT060401901 location
Burning Mouth Syndrome: Symptoms and Management
NCT070165551 location